| To: | Glaxo Group Limited (sheldon.r.pontaoe@gsk.com) |
| Subject: | TRADEMARK APPLICATION NO. 78527645 - AEROPALM - N/A |
| Sent: | 7/15/05 4:08:58 PM |
| Sent As: | ECOM114@USPTO.GOV |
| Attachments: |
UNITED STATES PATENT AND TRADEMARK OFFICE
|
SERIAL NO: 78/527645
APPLICANT: Glaxo Group Limited
|
|
|
CORRESPONDENT ADDRESS: SHELDON R. PONTAOE |
RETURN ADDRESS: Commissioner for Trademarks P.O. Box 1451 Alexandria, VA 22313-1451
If no fees are enclosed, the address should include the words "Box Responses - No Fee." |
|
MARK: AEROPALM
|
|
|
CORRESPONDENT’S REFERENCE/DOCKET NO: N/A
CORRESPONDENT EMAIL ADDRESS: |
Please provide in all correspondence:
1. Filing date, serial number, mark and applicant's name. 2. Date of this Office Action. 3. Examining Attorney's name and Law Office number. 4. Your telephone number and email address.
|
Serial Number 78527645
EXAMINER’S AMENDMENT
AMENDMENTS AUTHORIZED: As authorized by Sheldon R. Pontaoe, Esq., on July 15, 2005, the application is amended as noted below. If Applicant disagrees with or objects to any of the amendments below, please notify the undersigned attorney immediately, otherwise, no response is necessary. See TMEP § 707.
ADVISORY—AMENDMENTS TO GOODS: If the goods have been amended below, any future amendments must be in accordance with 37 C.F.R. § 2.71(a) and TMEP § 1402.07(e).
The Office records have been searched and no similar registered or pending mark has been found that would bar registration under Section 2(d) of the Trademark Act, 15 U.S.C. § 1052(d) (2003). TMEP § 704.02.
The following claim of ownership is added to the record:
Applicant is the owner of U.S. Registration No. 2208465.
37 C.F.R. § 2.36; TMEP § 812.
The identification of goods is amended to read as follows:
International Class 5—Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; and skin and tissue repair preparations for medical use.
TMEP § 1402.01(e).
Thank you for your cooperation and time in resolving the foregoing issues.
Sincerely,
/Judy Helfman/
Judith M. Helfman
USPTO - Trademarks
Law Office 114
(571) 272-5892 direct line